Venture Capital

• Myth busters: Why some things you hear about venture capital are wrong.
  (November 18, 2009) A record 500-plus people attended Wisconsin's largest early stage investing conference this month and another 250 rubbed shoulders in the...
• FluGen fighting flaws in flu vaccine industry
  (November 16, 2009) A small Madison company seeks funds to bring to market two technologies it believes will make flu vaccine production less...
• Wound Management Technologies Inc. solicits technology and development partners to leverage infrastructure for biotech and genetics
  (November 11, 2009) The BioPharma Management Technologies Division of Wound Management Technologies, Inc., (WNDM) will search for partners to aid in leveraging its...
• Central Signal gets $700K grant for wireless sensor networks
  (November 11, 2009) Central Signal, LLC, a Madison-based company, has been awarded a $700,000 SBIR Phase II grant entitled “Cost Effective, Power Efficient,...
• Alice.com closes $6 million in new funding, raises total investment to $10.4M for online household goods shopping site
  (November 10, 2009) As consumers seek to make their essential shopping dollars go further and save more money, Alice.com, an on-line platform that...
• Preparing for your next investor presentation
  (November 9, 2009) With a number of venture conferences this fall, including the upcoming MidAmerica Healthcare Venture Forum that is being held in...
• Bits of destruction hit the venture capital business
  (November 9, 2009) Venture capital (VC) funds like to invest in disruptive change, but what they really love is the stable, change-resistant nature...
• Ideas to Profits Conference encourages innovation in Wisconsin
  (November 6, 2009) Inventors seeking ways to move their product ideas forward toward commercialization found a wealth of information and resources at the...
• Private equity investor turnout will be strong for Nov. 10-11 Wisconsin Early Stage Symposium
  (November 5, 2009) ...
• Merck CEO 'actively looking' for biotech deals
  (November 5, 2009) Merck CEO `Actively Looking' for Biotech Deals...A day after closing Merck's $41 billion takeover of Schering-Plough, Merck CEO Dick Clark...